A multicenter Phase II study evaluating the efficacy, safety and pharmacokinetics of trastuzumab emtansine in Japanese patients with heavily pretreated HER2-positive locally recurrent or metastatic breast cancer

Masahiro Kashiwaba, Yoshinori Ito, Shintaro Takao, Hiroyoshi Doihara, Yoshiaki Rai, Kazumitsu Kanatani, Shigemitsu Takashima, Norikazu Masuda

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A multicenter Phase II study evaluating the efficacy, safety and pharmacokinetics of trastuzumab emtansine in Japanese patients with heavily pretreated HER2-positive locally recurrent or metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences